Stocks · Health care · Surgical & Medical Instruments & Apparatus

ResMed|

RMD Clue Score85
United States Fiscal year ends June CIK 0000943819 Results filed 29 Oct 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Michael J Rider
23 Oct 2026
Global General Counsel
Sold on a plan
400
$255.00
$102.00K
Michael J. Farrell
7 Oct 2026
Chairman and CEO
Sold after exercise
4,991
$226.33
$1.13M
Michael J. Farrell
8 Sep 2026
Chairman and CEO
Sold after exercise
4,991
$222.44
$1.11M
Peter C Farrell
2 Sep 2026
Director
Sold on a plan
970
$234.73
$227.69K
Michael J. Farrell
7 Aug 2026
Chairman and CEO
Sold after exercise
4,991
$205.69
$1.03M
Peter C Farrell
5 Aug 2026
Director
Sold on a plan
8,000
$225.00
$1.80M
Michael J. Farrell
7 Jul 2026
Chairman and CEO
Sold after exercise
4,991
$218.55
$1.09M
Michael J. Farrell
8 Jun 2026
Chairman and CEO
Sold after exercise
4,991
$193.96
$968.06K
Michael J. Farrell
7 May 2026
Chairman and CEO
Sold after exercise
4,991
$207.82
$1.04M
Michael J. Farrell
7 Apr 2026
Chairman and CEO
Sold after exercise
4,991
$225.50
$1.13M
Peter C Farrell
1 Apr 2026
Director
Sold on a plan
2,000
$225.00
$450.00K
Brett Sandercock
1 Apr 2026
Chief Financial Officer
Sold on a plan
1,000
$224.31
$224.31K
Michael J. Farrell
9 Mar 2026
Chairman and CEO
Sold after exercise
4,991
$251.03
$1.25M
Peter C Farrell
4 Mar 2026
Director
Sold on a plan
2,000
$260.22
$520.44K
Brett Sandercock
2 Mar 2026
Chief Financial Officer
Sold on a plan
1,000
$254.30
$254.30K
Michael J. Farrell
9 Feb 2026
Chairman and CEO
Sold after exercise
4,991
$273.78
$1.37M
Michael J Rider
4 Feb 2026
Global General Counsel
Sold on a plan
50
$260.00
$13.00K
Peter C Farrell
4 Feb 2026
Director
Sold on a plan
2,000
$251.31
$502.62K
Brett Sandercock
2 Feb 2026
Chief Financial Officer
Sold on a plan
1,000
$257.03
$257.03K
Michael J. Farrell
7 Jan 2026
Chairman and CEO
Sold after exercise
4,991
$248.46
$1.24M
Peter C Farrell
7 Jan 2026
Director
Sold on a plan
2,000
$248.83
$497.66K
Michael J Rider
2 Jan 2026
Global General Counsel
Sold on a plan
50
$241.75
$12.09K
Brett Sandercock
2 Jan 2026
Chief Financial Officer
Sold on a plan
1,000
$241.75
$241.75K
Michael J. Farrell
8 Dec 2025
Chairman and CEO
Sold after exercise
4,991
$251.41
$1.25M
Peter C Farrell
3 Dec 2025
Director
Sold on a plan
2,000
$251.47
$502.94K
Brett Sandercock
1 Dec 2025
Chief Financial Officer
Sold on a plan
1,000
$244.16
$244.16K
Michael J Rider
1 Dec 2025
Global General Counsel
Sold on a plan
50
$244.16
$12.21K
Witte Jan De
25 Nov 2025
Director
Sold on a plan
2,055
$255.00
$524.03K
Peter C Farrell
14 Nov 2025
Director
Exercised, kept
11,442
$101.64
$1.16M
Peter C Farrell
12 Nov 2025
Director
Sold on a plan
2,000
$252.05
$504.10K
Witte Jan De
11 Nov 2025
Director
Sold on a plan
487
$250.25
$121.87K
Michael J. Farrell
7 Nov 2025
Chairman and CEO
Sold after exercise
8,011
$249.75
$2.00M

What was left out

Form 4 filings counted 58
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 19
Sales straight out of an exercise 12
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 159,008
History held since 3 Oct 2006